Skip to main content
. 2016 Jan 27;2016(1):CD009210. doi: 10.1002/14651858.CD009210.pub2

Colson 1992.

Methods Prospective randomized controlled trial
Participants Scheduled for infrarenal aortic surgery because of aortic aneurysm (n = 8) or aorta occlusive disease (n = 16)
Mean age (years): 1. 63 ± 1; 2. 63 ± 3; 3. 58 ± 4
Sample size (male): 24(23)
Interventions 2 days before surgery, participants were allocated to 1 of 3 groups in randomized, double‐blind fashion: 1. control group; 2. nicardipine group; 3. enalapril group. The enalapril group received enalapril (10 mg twice daily), whereas the control and nicardipine groups received a placebo (1 tablet twice daily). The last dose of either enalapril or placebo was given at the time of preanaesthetic medication, approximately 2 h before surgery. Both treatments were well tolerated. At skin incision, nicardipine was administered to the nicardipine group (2 mg IV bolus injection, then 2 mg/h), and placebo (5% glucose solution) was infused in participants in the other groups
Outcomes Glomerular filtration rate
Notes Intervention started 2 days before surgery and continued until 2 h before surgery
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Random allocation, but no details available
Allocation concealment (selection bias) Unclear risk No relevant description, and no further details available
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double blind, but no details available
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No relevant description
Incomplete outcome data (attrition bias) 
 All outcomes High risk No relevant description
Selective reporting (reporting bias) Unclear risk Protocol inaccessible
Other bias Unclear risk Funding source not reported